Struggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO ...

TheStreet.comStruggling Sanofi Sends Cancer SOS to Regeneron and Another Vanity Biotech IPO ...TheStreet.comOn Tuesday, the two companies paired up again, this time in a big-money collaboration to develop new cancer immunotherapies. Financial terms of the deal can be found here, but all you really need to know is that Sanofi badly trails its Big Pharma ...Sanofi to Join Regeneron in Quest to Unleash Immune System on CancerNew York TimesSanofi links with Regeneron in $2.2 billion cancer drug pushYahoo NewsSanofi Joins Regeneron in $2.2 Billion Pact for Cancer TherapiesBloombergNews-Medical.net -PMLiVEall 40 news articles »

Share this post